Scott Harris

Scott Harris

Company: Altimmune

Job title: Chief Medical Officer

Seminars:

Beyond GLP-1 Receptor Agonists: Examining Innovative Mechanisms of Action & Clinical Data for the Treatment of Obesity 11:30 am

From GLP-1 monotherapy to triple agonists: enhancing effective drug-based therapy for weight loss to rival bariatric surgery Exploring advances in dual receptor agonists, triple receptor agonists and combination therapies for the treatment of obesity, NASH, and metabolic dysfunction Assessing the comparative benefits of different agents and mechanisms of action in these conditionsRead more

day: Day 1 Stream 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.